Medizinische Universität Graz - Research portal

Logo MUG Resarch Portal

Peintinger Florentia |

** = Publications listed in SCI/SSCI/Pubmed

2025

Full paper/article (Journal)

** Banys-Paluchowski, M; Hartmann, S; Basali, T; Gasparri, ML; de, Boniface, J; Gentilini, OD; Cakmak, GK; Ditsch, N; Stickeler, E; Schlichting, E; Rubio, I; Peintinger, F; Untch, M; Mau, C; Federspiel, FK; Bucher, S; Ramaker, K; Paluchowski, P; Bauer, L; Riemer, S; Langanke, D; Leuf, TD; Schnabel, J; von, Abel, E; Solbach, C; Ovalle, SC; Hilmer, K; Bjelic-Radisic, V; Stahl, N; Sanchez-Mendez, JI; Hagen, V; Hansen, MH; Krawczyk, N; Sezen, BA; Jursik, K; Thill, M; Kolberg, HC; Reimer, T; Ruf, F; Wihlfahrt, K; Rief, A; Berger, T; Schmidt, E; Tauber, N; Fröhlich, S; Kühn, T Radar reflectors for marking of target lymph nodes in initially node-positive patients receiving neoadjuvant chemotherapy for breast cancer-a subgroup analysis of the prospective AXSANA (EUBREAST-03) trial.
Breast Cancer Res Treat. 2025; Doi: 10.1007/s10549-025-07635-4
Web of Science PubMed FullText FullText_MUG

 

2024

Abstract (Journal)

** Banys-Paluchowski, M; Basali, T; Hartmann, S; de Boniface, J; Gentilini, OD; Stickeler, E; Mau, C; Ruf, F; Froehlich, S; Gasparri, ML; Thill, M; Peintinger, F; Cakmak, GK; Rubio, IT; Langanke, D; Ovalle, SC; Riemer, S; Rody, A; Schlichting, E; Kuehn, T Radar reflectors for marking of target lymph nodes in patients receiving neo-adjuvant chemotherapy for breast cancer: A subgroup analysis of the prospective AXSANA (EUBREAST-03) trial
J CLIN ONCOL. 2024; 42(16): [Poster]
Web of Science

 

2022

Abstract (Journal)

** Banys-Paluchowski, M; Hartmann, S; Stickeler, E; De Boniface, J; Gentilini, O; Frohlich, S; Thill, M; Ruf, F; Hauptmann, M; Cakmak, GK; Rubio, IT; Gasparri, ML; Kontos, M; Bonci, EA; Niinikoski, L; Di Micco, R; Murawa, D; Pinto, D; Peintinger, F; Dostalek, L; Solbach, C; Appelgren, M; Blohmer, JU; Thiemann, E; Weigel, M; Kaltenecker, G; Ramaker, K; Schrauder, MG; Kuhn, T AXSANA - EUBREAST 3 (AXillary Surgery After NeoAdjuvant Treatment): An international prospective multicenter cohort study of the EUBREAST study group to evaluate different surgical methods of axillary staging (sentinel lymph node biopsy, targeted axillary dissection, axillary dissection) in clinically node-positive breast cancer patients treated with neoadjuvant chemotherapy (NCT04373655)
ONCOL RES TREAT. 2022; 45(SUPPL 3):24-25. [Onlinepräsentation]
Web of Science

 

** Rief, A; Kuhn, T; Peintinger, F; Hartmann, S; Stickeler, E; de Boniface, J; Gentilini, O; Ruf, F; Frohlich, S; Thill, M; Hauptmann, M; Berger, T; Wihlfahrt, K; Cakmak, GK; Rubio, TI; Gasparri, LM; Kontos, M; Bonci, EA; Niinikoski, L; Murawa, D; Appelgren, M; Hahn, M; Pristauz-Telsnigg, G; Czihak, J; Banys-Paluchowski, M AXSANA - AXillary Surgery After NeoAdjuvant Treatment: A prospective, multicenter Cohort Study by the EUBREAST Study Group to evaluate different surgical Procedures of axillary Staging in initially node-positive Patients after neoadjuvant Chemotherapy
GEBURTSH FRAUENHEILK. 2022; 82(6): S47-S48. Doi: 10.1055/s-0042-1750235 [Poster]
Web of Science FullText FullText_MUG

 

** Sieghartsleitner, E; Sunitsch, S; Rief, A; Regitnig, P; Geigl, J; Tamussino, K; Peintinger, F Somatic gene alterations in endometrial cancer and correlation with germline alterations
GEBURTSH FRAUENHEILK. 2022; 82(10):E162-E163. Doi: 10.1055/s-0042-1757051 [Poster]
Web of Science FullText FullText_MUG

 

** Sieghartsleitner, E; Sunitsch, S; Rief, A; Regnitnig, P; Geigl, J; Tamussino, K; Peintinger, F Somatic Gene Changes in Endometrial Cancer and Correlation with Germline Changes
GEBURTSH FRAUENHEILK. 2022; 82(6):S48-S49. Doi: 10.1055/s-0042-1750237
Web of Science FullText FullText_MUG

 

2021

Full paper/article (Journal)

** Reitsamer, R; Peintinger, F; Forsthuber, E; Sir, A The applicability of Magseed® for targeted axillary dissection in breast cancer patients treated with neoadjuvant chemotherapy.
Breast. 2021; 57:113-117 Doi: 10.1016/j.breast.2021.03.008 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Review

** Banys-Paluchowski, M; Gasparri, ML; de, Boniface, J; Gentilini, O; Stickeler, E; Hartmann, S; Thill, M; Rubio, IT; Di, Micco, R; Bonci, EA; Niinikoski, L; Kontos, M; Karadeniz, Cakmak, G; Hauptmann, M; Peintinger, F; Pinto, D; Matrai, Z; Murawa, D; Kadayaprath, G; Dostalek, L; Nina, H; Krivorotko, P; Classe, JM; Schlichting, E; Appelgren, M; Paluchowski, P; Solbach, C; Blohmer, JU; Kühn, T; The, Axsana, Study, Group Surgical Management of the Axilla in Clinically Node-Positive Breast Cancer Patients Converting to Clinical Node Negativity through Neoadjuvant Chemotherapy: Current Status, Knowledge Gaps, and Rationale for the EUBREAST-03 AXSANA Study.
Cancers (Basel). 2021; 13(7): Doi: 10.3390/cancers13071565 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Abstract (Journal)

** Sieghartsleitner, E; Sunitsch, S; Regitnig, P; Tamussino, K; Geigl, J; Peintinger, F Survey of somatic Gene Changes in Patients with Endometrial Cancer and Correlation with Germline Alterations
GEBURTSH FRAUENHEILK. 2021; 81(06):E28-E28. Doi: 10.1055/s-0041-1730510 [Poster]
Web of Science FullText FullText_MUG

 

** Sieghartsleitner, EA; Sunitsch, S; Regitnig, P; Tamussino, K; Geigl, J; Peintinger, F Survey of somatic Gene Changes in Endometrial Cancer and Correlation with Changes in the Germline
GEBURTSH FRAUENHEILK. 2021; 81(04):E7-E7. Doi: 10.1055/s-0041-1726595 [Poster]
Web of Science FullText FullText_MUG

 

Comment

** Reitsamer, R; Peintinger, F; Klaassen-Federspiel, F; Sir, A The iBAG study-a milestone?
J Surg Oncol. 2021; 123(8):1845 Doi: 10.1002/jso.26368
Web of Science PubMed FullText FullText_MUG

 

2019

Full paper/article (Journal)

** Reitsamer, R; Peintinger, F; Klaassen-Federspiel, F; Sir, A Prepectoral direct-to-implant breast reconstruction with complete ADM or synthetic mesh coverage - 36-Months follow-up in 200 reconstructed breasts.
Breast. 2019; 48: 32-37. Doi: 10.1016/j.breast.2019.08.002
Web of Science PubMed FullText FullText_MUG

 

Review

** Peintinger, F National Breast Screening Programs across Europe.
Breast Care (Basel). 2019; 14(6):354-358 Doi: 10.1159/000503715 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Correspondence

** Gentilini, OD; De Boniface, J; Classe, JM; Peintinger, F; Reimer, T; Reitsamer, R; Rubio, I; Smidt, M; Kuehn, T A gap analysis of opportunities and priorities for breast surgical research.
LANCET ONCOL. 2019; 20(1): e1-e1. Doi: 10.1016/S1470-2045(18)30916-1
Web of Science PubMed FullText FullText_MUG

 

2018

Full paper/article (Journal)

** Kühn, T; Classe, JM; Gentilini, OD; Tinterri, C; Peintinger, F; de Boniface, J Current Status and Future Perspectives of Axillary Management in the Neoadjuvant Setting.
Breast Care (Basel). 2018; 13(5):337-341 Doi: 10.1159/000492437 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Review

** Peintinger, F; Reitsamer, R; Smidt, ML; Kühn, T; Liedtke, C Lymph Nodes in Breast Cancer - What Can We Learn from Translational Research?
Breast Care (Basel). 2018; 13(5):342-347 Doi: 10.1159/000492435 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2016

Full paper/article (Journal)

** Kammerer, S; Sokolowski, A; Hackl, H; Platzer, D; Jahn, SW; El-Heliebi, A; Schwarzenbacher, D; Stiegelbauer, V; Pichler, M; Rezania, S; Fiegl, H; Peintinger, F; Regitnig, P; Hoefler, G; Schreibmayer, W; Bauernhofer, T KCNJ3 is a new independent prognostic marker for estrogen receptor positive breast cancer patients.
Oncotarget. 2016; 7(51):84705-84717 Doi: 10.18632/oncotarget.13224 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2015

Full paper/article (Journal)

** Fastner, G; Reitsamer, R; Ziegler, I; Zehentmayr, F; Fussl, C; Kopp, P; Peintinger, F; Greil, R; Fischer, T; Deutschmann, H; Sedlmayer, F IOERT as anticipated tumor bed boost during breast-conserving surgery after neoadjuvant chemotherapy in locally advanced breast cancer--results of a case series after 5-year follow-up.
Int J Cancer. 2015; 136(5): 1193-1201. Doi: 10.1002/ijc.29064 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Peintinger, F; Sinn, B; Hatzis, C; Albarracin, C; Downs-Kelly, E; Morkowski, J; Gould, R; Symmans, WF Reproducibility of residual cancer burden for prognostic assessment of breast cancer after neoadjuvant chemotherapy.
MODERN PATHOL. 2015; 28(7): 913-920. Doi: 10.1038/modpathol.2015.53 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Provenzano, E; Bossuyt, V; Viale, G; Cameron, D; Badve, S; Denkert, C; MacGrogan, G; Penault-Llorca, F; Boughey, J; Curigliano, G; Dixon, JM; Esserman, L; Fastner, G; Kuehn, T; Peintinger, F; von Minckwitz, G; White, J; Yang, W; Symmans, WF; Residual Disease Characterization Working Group of the Breast International Group-North American Breast Cancer Group Collaboration Standardization of pathologic evaluation and reporting of postneoadjuvant specimens in clinical trials of breast cancer: recommendations from an international working group.
MODERN PATHOL. 2015; 28(9): 1185-1201. Doi: 10.1038/modpathol.2015.74 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Reitsamer, R; Peintinger, F Prepectoral implant placement and complete coverage with porcine acellular dermal matrix: a new technique for direct-to-implant breast reconstruction after nipple-sparing mastectomy.
J PLAST RECONSTR AES. 2015; 68(2): 162-167. Doi: 10.1016/j.bjps.2014.10.012
Web of Science PubMed FullText FullText_MUG

 

Review

** Bossuyt, V; Provenzano, E; Symmans, WF; Boughey, JC; Coles, C; Curigliano, G; Dixon, JM; Esserman, LJ; Fastner, G; Kuehn, T; Peintinger, F; von Minckwitz, G; White, J; Yang, W; Badve, S; Denkert, C; MacGrogan, G; Penault-Llorca, F; Viale, G; Cameron, D; Breast International Group-North American Breast Cancer Group (BIG-NABCG) collaboration Recommendations for standardized pathological characterization of residual disease for neoadjuvant clinical trials of breast cancer by the BIG-NABCG collaboration.
ANN ONCOL. 2015; 26(7): 1280-1291. Doi: 10.1093/annonc/mdv161 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Abstract (Journal)

** Peintinger, F; Zurl, B; Fastner, G; Sedlmayer, F; Schermann, C; Reitsamer, R Low Locoregional Recurrence Rates After Neoadjuvant Therapy Followed by Small Surgical Resection Volume and Intraoperative Radiotherapy
ANN SURG ONCOL. 2015; 22: 87-87.-16th Annual Meeting of the American-Society-of-Breast-Surgeons; APR 29-MAY 03, 2015; Orlando, FL. Doi: 10.1093/annonc/mdu068.2 [Poster]
Web of Science FullText FullText_MUG

 

2014

Full paper/article (Journal)

** Parvizi, D; Haas, F; Peintinger, F; Hubmer, M; Rappl, T; Koch, H; Schintler, M; Spendel, S; Kamolz, LP; Wurzer, P; Tuca, A; Fuchsjaeger, M; Weinke, R First experience using contrast-enhanced ultrasound to evaluate vascularisation of acellular dermal matrices after implant-based breast reconstruction.
Breast J. 2014; 20(5):461-467 Doi: 10.1111/tbj.12301
Web of Science PubMed FullText FullText_MUG

 

** Rordorf, T; Hassan, AA; Azim, H; Alexandru, E; Er, O; Gokmen, E; Güral, Z; Mardiak, J; Minchev, V; Peintinger, F; Szendroi, M; Takac, I; Tesarova, P; Vorobiof, D; Vrbanec, D; Yildiz, R; Yücel, S; Zekri, J; Oyan, B; Central European Cooperative Oncology Group (CECOG); Swiss Group for Clinical Cancer Research (SAKK) Bone health in breast cancer patients: a comprehensive statement by CECOG/SAKK Intergroup.
Breast. 2014; 23(5):511-525 Doi: 10.1016/j.breast.2014.05.023 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

Review

** Peintinger, F Using molecular profiles to tailor treatment in breast cancer: are they ready for prime time?
Curr Opin Obstet Gynecol. 2014; 26(1):21-26 Doi: 10.1097/GCO.0000000000000041
Web of Science PubMed FullText FullText_MUG

 

Abstract (Journal)

** Kammerer, S; Sokolowski, A; Hackl, H; Jahn, S; Asslaber, M; Symmans, F; Peintinger, F; Regitnig, P; Schreibmayer, W; Bauernhofer, T OVEREXPRESSION OF G PROTEIN-ACTIVATED INWARD RECTIFIER POTASSIUM CHANNEL 1 (GIRK1) IS ASSOCIATED WITH LYMPH NODE METASTASIS AND POOR PROGNOSIS IN BREAST CANCER
ANN ONCOL. . 2014; 25: -IMPAKT Breast Cancer Conference; MAY 08-10, 2014; Brussels, BELGIUM. Doi: 10.1093/annonc/mdu066.21 [Poster]
Web of Science FullText FullText_MUG

 

2013

Full paper/article (Journal)

** AGO; DGS; SGS; ÖGS; Panelists; Executive Board Members; Hoffmann, J; Souchon, R; Lebeau, A; Öhlschlegel, C; Gruber, G; Rageth, C; Weber, W; Harbeck, N; Janni, W; Kreipe, H; Fitzal, F; Resch, A; Bago-Horvath, Z; Peintinger, F German, Austrian and Swiss consensus conference on the diagnosis and local treatment of the axilla in breast cancer.
Eur J Cancer. 2013; 49(10): 2277-2283. Doi: 10.1016/j.ejca.2013.01.034
Web of Science PubMed FullText FullText_MUG

 

2012

Full paper/article (Journal)

** Mazouni, C; Reitsamer, R; Rimareix, F; Stranzl, H; Uzan, C; Garbay, JR; Delaloge, S; Peintinger, F; The positive non-sentinel status is not the main decisional factor for chemotherapy assignment in breast cancer with micrometastatic disease in the sentinel lymph node.
J Surg Oncol. 2012; 106(6):703-707 Doi: 10.1002/jso.23188
Web of Science PubMed FullText FullText_MUG

 

2011

Comment

** Peintinger, F Clinical use of nomograms for breast cancer.
J Surg Oncol. 2011; 103(8): 745-745. Doi: 10.1002/jso.21761
Web of Science PubMed FullText FullText_MUG

 

2010

Full paper/article (Journal)

** Shinde, SS; Forman, MR; Kuerer, HM; Yan, K; Peintinger, F; Hunt, KK; Hortobagyi, GN; Pusztai, L; Symmans, WF Higher parity and shorter breastfeeding duration: association with triple-negative phenotype of breast cancer.
Cancer. 2010; 116(21): 4933-4943. Doi: 10.1002/cncr.25443 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Symmans, WF; Hatzis, C; Sotiriou, C; Andre, F; Peintinger, F; Regitnig, P; Daxenbichler, G; Desmedt, C; Domont, J; Marth, C; Delaloge, S; Bauernhofer, T; Valero, V; Booser, DJ; Hortobagyi, GN; Pusztai, L Genomic Index of Sensitivity to Endocrine Therapy for Breast Cancer.
J Clin Oncol. 2010; 28(27): 4111-4119. Doi: 10.1200/JCO.2010.28.4273 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Abstract (Journal)

** Peintinger, F; Mazouni, C; Stranzl, H; Ralph, G; Reitsamer, R Micrometastases in sentinel lymph nodes in patients with breast carcinoma: indication for chemotherapy.
GEBURTSH FRAUENHEILK. 2010; 70(5):P51--Jahrestagung der OEGGG 2010 ; 2.-5. Juni 2010; Zell/See. [Poster]
Web of Science

 

** Steger, GG; Mlineritsch, B; Bartsch, R; Pluschnig, U; Petru, E; Peintinger, F; Sevelda, P; Greil, R Non-pegylated liposomal doxorubicin in metastatic breast cancer (MBC) - Results from an Austrian post marketing surveillance programme
ONKOLOGIE. 2010; 33: 55-55. [Keynote lecture]
Web of Science

 

2009

Full paper/article (Journal)

** Gonzalez-Angulo, AM; Litton, JK; Broglio, KR; Meric-Bernstam, F; Rakkhit, R; Cardoso, F; Peintinger, F; Hanrahan, EO; Sahin, A; Guray, M; Larsimont, D; Feoli, F; Stranzl, H; Buchholz, TA; Valero, V; Theriault, R; Piccart-Gebhart, M; Ravdin, PM; Berry, DA; Hortobagyi, GN High risk of recurrence for patients with breast cancer who have human epidermal growth factor receptor 2-positive, node-negative tumors 1 cm or smaller.
J Clin Oncol. 2009; 27(34):5700-5706 Doi: 10.1200/JCO.2009.23.2025 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Haid, A; Kühn, T; Goyal, A; Tausch, C; Peintinger, F; Schrenk, P; Gallowitsch, H Sentinel Node Biopsy in Breast Cancer: Clinical Implication - Standard of Care - Fututre Prospects.
Breast Care (Basel). 2009; 4(3): 195-202. Doi: 10.1159/000218329 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

Abstract (Journal)

** Peintinger, F; Litscher, B; Frank, K; Schmolzer, L; Ralph, G; Stranzl, H Reduction of wound infection rate after operative therapy of breast carcinoma with hydrofiber/foil- combination dressing in wound management
GEBURTSH FRAUENHEILK. 2009; 69(5):P141--OEGGG 2009; 10.-13 Juni 2009; Wien. [Oral Communication]
Web of Science

 

2008

Full paper/article (Journal)

** Peintinger, F; Buzdar, AU; Kuerer, HM; Mejia, JA; Hatzis, C; Gonzalez-Angulo, AM; Pusztai, L; Esteva, FJ; Dawood, SS; Green, MC; Hortobagyi, GN; Symmans, WF Hormone receptor status and pathologic response of HER2-positive breast cancer treated with neoadjuvant chemotherapy and trastuzumab.
Ann Oncol. 2008; 19(12): 2020-2025. Doi: 10.1093/annonc/mdn427 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Peintinger, F; Kuerer, HM; McGuire, SE; Bassett, R; Pusztai, L; Symmans, WF Residual specimen cellularity after neoadjuvant chemotherapy for breast cancer.
Br J Surg. 2008; 95(4): 433-437. Doi: 10.1002/bjs.6044
Web of Science PubMed FullText FullText_MUG

 

** Reitsamer, R; Menzel, C; Glueck, S; Hitzl, W; Peintinger, F Predictors of mastectomy in a certified breast center - the surgeon is an independent risk factor.
Breast J. 2008; 14(4): 324-329. Doi: 10.1111/j.1524-4741.2008.00592.x
Web of Science PubMed FullText FullText_MUG

 

** Reitsamer, R; Sedlmayer, F; Kopp, M; Kametriser, G; Menzel, C; Glueck, S; Nairz, O; Deutschmann, H; Merz, F; Peintinger, F Concepts and techniques of intraoperative radiotherapy (IORT) for breast cancer.
Breast Cancer. 2008; 15(1): 40-46. Doi: 10.1007/s12282-007-0001-4
Web of Science PubMed FullText FullText_MUG

 

Abstract (Journal)

** Peintinger, F; Regitnig, P; Leitner, G; Ralph, G; Stranzl-Lawatsch, H Prognosis of patients with small, nodal negative mamma carcinoma in association to hormone receptor and HER2-Expression
GEBURTSH FRAUENHEILK. 2008; 68(4):433-434. [Oral Communication]
Web of Science

 

** Stranzl-Lawatsch, H; Regitnig, P; Peintinger, F Female patients with low-risk mamma carcinoma and HER2-new status
STRAHLENTHER ONKOL. 2008; 184: 65-65. [Oral Communication]
Web of Science

 

2007

Full paper/article (Journal)

** Dawood, S; Gonzalez-Angulo, AM; Peintinger, F; Broglio, K; Symmans, WF; Kau, SW; Islam, R; Hortobagyi, GN; Buzdar, AU Efficacy and safety of neoadjuvant trastuzumab combined with paclitaxel and epirubicin: a retrospective review of the M. D. Anderson experience.
Cancer. 2007; 110(6): 1195-1200. Doi: 10.1002/cncr.22895 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Mazouni, C; Peintinger, F; Wan-Kau, S; Andre, F; Gonzalez-Angulo, AM; Symmans, WF; Meric-Bernstam, F; Valero, V; Hortobagyi, GN; Pusztai, L Residual ductal carcinoma in situ in patients with complete eradication of invasive breast cancer after neoadjuvant chemotherapy does not adversely affect patient outcome.
J Clin Oncol. 2007; 25(19): 2650-2655. Doi: 10.1200/JCO.2006.08.2271 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Peintinger, F; Anderson, K; Mazouni, C; Kuerer, HM; Hatzis, C; Lin, F; Hortobagyi, GN; Symmans, WF; Pusztai, L Thirty-gene pharmacogenomic test correlates with residual cancer burden after preoperative chemotherapy for breast cancer.
Clin Cancer Res. 2007; 13(14): 4078-4082. Doi: 10.1158/1078-0432.CCR-06-2600 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Symmans, WF; Peintinger, F; Hatzis, C; Rajan, R; Kuerer, H; Valero, V; Assad, L; Poniecka, A; Hennessy, B; Green, M; Buzdar, AU; Singletary, SE; Hortobagyi, GN; Pusztai, L Measurement of residual breast cancer burden to predict survival after neoadjuvant chemotherapy.
J Clin Oncol. 2007; 25(28): 4414-4422. Doi: 10.1200/JCO.2007.10.6823 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

2006

Full paper/article (Journal)

** Boughey, JC; Peintinger, F; Meric-Bernstam, F; Perry, AC; Hunt, KK; Babiera, GV; Singletary, SE; Bedrosian, I; Lucci, A; Buzdar, AU; Pusztai, L; Kuerer, HM Impact of preoperative versus postoperative chemotherapy on the extent and number of surgical procedures in patients treated in randomized clinical trials for breast cancer.
Ann Surg. 2006; 244(3): 464-470. Doi: 10.1097/01.sla.0000234897.38950.5c [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Peintinger, F; Georgoulopoulos, A; Ralph, G; Piswanger, C Retrospective comparison of chemotherapy-induced myelotoxicity in patients with ovarian cancer under and over 60 years of age.
J Chemother. 2006; 18(6): 656-661. Doi: 10.1179/joc.2006.18.6.656
Web of Science PubMed FullText FullText_MUG

 

** Peintinger, F; Kuerer, HM; Anderson, K; Boughey, JC; Meric-Bernstam, F; Singletary, SE; Hunt, KK; Whitman, GJ; Stephens, T; Buzdar, AU; Green, MC; Symmans, WF Accuracy of the combination of mammography and sonography in predicting tumor response in breast cancer patients after neoadjuvant chemotherapy.
Ann Surg Oncol. 2006; 13(11): 1443-1449. Doi: 10.1245/s10434-006-9086-9
Web of Science PubMed FullText FullText_MUG

 

** Peintinger, F; Symmans, WF; Gonzalez-Angulo, AM; Boughey, JC; Buzdar, AU; Yu, TK; Hunt, KK; Singletary, SE; Babiera, GV; Lucci, A; Meric-Bernstam, F; Kuerer, HM The safety of breast-conserving surgery in patients who achieve a complete pathologic response after neoadjuvant chemotherapy.
Cancer. 2006; 107(6): 1248-1254. Doi: 10.1002/cncr.22111 [OPEN ACCESS]
Web of Science PubMed FullText FullText_MUG

 

** Reitsamer, R; Sedlmayer, F; Kopp, M; Kametriser, G; Menzel, C; Deutschmann, H; Nairz, O; Hitzl, W; Peintinger, F The Salzburg concept of intraoperative radiotherapy for breast cancer: results and considerations.
Int J Cancer. 2006; 118(11): 2882-2887. Doi: 10.1002/ijc.21727
Web of Science PubMed FullText FullText_MUG

 

** Stranzl, H; Ofner, P; Peintinger, F Postoperative irradiation in breast cancer patients with one to three positive axillary lymph nodes. Is there an impact of axillary extranodal tumor extension on locoregional and distant control?
Strahlenther Onkol. 2006; 182(10):583-588 Doi: 10.1007/s00066-006-1562-4
Web of Science PubMed FullText FullText_MUG

 

2005

Full paper/article (Journal)

** Kroiss, R; Winkler, V; Bikas, D; Fleischmann, E; Mainau, C; Frommlet, F; Muhr, D; Fuerhauser, C; Tea, M; Bittner, B; Kubista, E; Oefner, PJ; Bauer, P; Wagner, TM; Austrian Hereditary Breast and Ovarian Cancer Group Younger birth cohort correlates with higher breast and ovarian cancer risk in European BRCA1 mutation carriers.
Hum Mutat. 2005; 26(6): 583-589. Doi: 10.1002/humu.20261
Web of Science PubMed FullText FullText_MUG

 

** Peintinger, F; Reitsamer, R; Ralph, G Implementation of sentinel lymph node biopsy with blue dye outside a specialized center: can we improve quality assurance?
Breast J. 2005; 11(2): 103-107. Doi: 10.1111/j.1075-122X.2005.21538.x
Web of Science PubMed FullText FullText_MUG

 

** Reitsamer, R; Peintinger, F; Prokop, E; Hitzl, W Pathological complete response rates comparing 3 versus 6 cycles of epidoxorubicin and docetaxel in the neoadjuvant setting of patients with stage II and III breast cancer.
Anticancer Drugs. 2005; 16(8): 867-870. Doi: 10.1097/01.cad.0000173475.59616.b4
Web of Science PubMed FullText FullText_MUG

 

Comment

** Reitsamer, R; Peintinger, F; Sedlmayer, F; Kopp, M; Cimpoca, W; Menzel, C Accelerated partial breast irradiation after conservative surgery for breast cancer.
Ann Surg. 2005; 242(1): 147-148. Doi: 10.1097/01.sla.0000169569.09715.c0 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

2004

Full paper/article (Journal)

** Reitsamer, R; Peintinger, F; Kopp, M; Menzel, C; Kogelnik, HD; Sedlmayer, F Local recurrence rates in breast cancer patients treated with intraoperative electron-boost radiotherapy versus postoperative external-beam electron-boost irradiation. A sequential intervention study.
Strahlenther Onkol. 2004; 180(1): 38-44. Doi: 10.1007/s00066-004-1190-9
Web of Science PubMed FullText FullText_MUG

 

** Reitsamer, R; Peintinger, F; Prokop, E; Rettenbacher, L; Menzel, C 200 Sentinel lymph node biopsies without axillary lymph node dissection -- no axillary recurrences after a 3-year follow-up.
Br J Cancer. 2004; 90(8): 1551-1554. Doi: 10.1038/sj.bjc.6601765 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Stranzl, H; Mayer, R; Ofner, P; Peintinger, F; Prettenhofer, U; Hackl, A Extracapsular extension in positive axillary lymph nodes in female breast cancer patients. Patterns of failure and indications for postoperative locoregional irradiation.
STRAHLENTHER ONKOL. 2004; 180(1): 31-37. Doi: 10.1007/s00066-004-1170-0
Web of Science PubMed FullText FullText_MUG

 

** Stranzl, H; Peintinger, F; Hackl, A Phyllodes tumor: an unexpected tumor of the breast. A report on six patients.
Strahlenther Onkol. 2004; 180(3):148-151 Doi: 10.1007/s00066-004-1182-9
Web of Science PubMed FullText FullText_MUG

 

** Stranzl, H; Peintinger, F; Ofner, P; Prettenhofer, U; Mayer, R; Hackl, A Regional nodal recurrence in the management of breast cancer patients with one to three positive axillary lymph nodes. Outcome of patients following tangential irradiation without a separate nodal field.
Strahlenther Onkol. 2004; 180(10):623-628 Doi: 10.1007/s00066-004-1241-2
Web of Science PubMed FullText FullText_MUG

 

Short report/Letter

** Peintinger, F; Leibl, S; Reitsamer, R; Moinfar, F Primary acinic cell carcinoma of the breast: a case report with long-term follow-up and review of the literature.
HISTOPATHOLOGY. 2004; 45(6): 645-648. Doi: 10.1111/j.1365-2559.2004.01957.x (- Case Report)
Web of Science PubMed FullText FullText_MUG

 

2003

Full paper/article (Journal)

** Peintinger, F; Reitsamer, R; Stranzl, H; Ralph, G Comparison of quality of life and arm complaints after axillary lymph node dissection vs sentinel lymph node biopsy in breast cancer patients.
Br J Cancer. 2003; 89(4):648-652 Doi: 10.1038/sj.bjc.6601150 [OPEN ACCESS]
Web of Science PubMed PUBMED Central FullText FullText_MUG

 

** Reitsamer, R; Menzel, C; Peintinger, F; Cimpoca, W; Glück, S; Sinzinger, G; Rettenbacher, L; Kässmann, H; Hoffmann, A; Prokop, E; Strasser, F; Kiesler, J; Hutarew, G; Dietze, O Sentinel lymph node biopsy in breast cancer patients--results and experience after 500 sentinel lymph node biopsies].
Gynakol Geburtshilfliche Rundsch. 2003; 43(2):98-103 Doi: 10.1159/000069162
PubMed FullText FullText_MUG

 

** Reitsamer, R; Peintinger, F; Prokop, E; Menzel, C; Cimpoca, W; Rettenbacher, L Sentinel lymph node biopsy alone without axillary lymph node dissection--follow up of sentinel lymph node negative breast cancer patients.
Eur J Surg Oncol. 2003; 29(3):221-223 Doi: 10.1053/ejso.2002.1320
Web of Science PubMed FullText FullText_MUG

 

** Reitsamer, R; Peintinger, F; Rettenbacher, L; Prokop, E Sentinel lymph node biopsy in breast cancer patients after neoadjuvant chemotherapy.
J Surg Oncol. 2003; 84(2):63-67 Doi: 10.1002/jso.10294
Web of Science PubMed FullText FullText_MUG

 

** Reitsamer, R; Peintinger, F; Rettenbacher, L; Prokop, E; Sedlmayer, F Subareolar subcutaneous injection of blue dye versus peritumoral injection of technetium-labeled human albumin to identify sentinel lymph nodes in breast cancer patients.
World J Surg. 2003; 27(12):1291-1294 Doi: 10.1007/s00268-003-7001-0
Web of Science PubMed FullText FullText_MUG

 

2002

Full paper/article (Journal)

** Greimel, E; Thiel, I; Peintinger, F; Cegnar, I; Pongratz, E Prospective assessment of quality of life of female cancer patients.
Gynecol Oncol. 2002; 85(1):140-147 Doi: 10.1006/gyno.2002.6586
Web of Science PubMed FullText FullText_MUG

 

** Reitsamer, R; Peintinger, F; Sedlmayer, F; Kopp, M; Menzel, C; Cimpoca, W; Glueck, S; Rahim, H; Kopp, P; Deutschmann, H; Merz, F; Brandis, M; Kogelnik, H Intraoperative radiotherapy given as a boost after breast-conserving surgery in breast cancer patients.
Eur J Cancer. 2002; 38(12):1607-1610 Doi: 10.1016/S0959-8049(02)00116-8
Web of Science PubMed FullText FullText_MUG

 

Abstract (Journal)

** Stranzl, H; Peintinger, F; Mayer, R; Prettenhofer, U; Guss, H; Hackl, A Uncommon cancer of the breast - Experiences in Graz
STRAHLENTHER ONKOL 2002 178: 27-27.
Web of Science

 

2001

Abstract (Journal)

** Peintinger, F; Reitsamer, R; Piswanger, C; Stranzl, H Quality of life and arm mobility after axillary lymph node dissection versus sentinel lymph node biopsy.
BREAST CANCER RES TREAT 2001 69: 220-220.
Web of Science

 

↑ Top of page / Navigation

© Med Uni Graz • Imprint